Corpus Intelligence IC Memo — HIGHLANDS REGIONAL REHAB HOSPITAL 2026-04-26 15:52 UTC
IC Memo — HIGHLANDS REGIONAL REHAB HOSPITAL
Investment Committee Memorandum | TX | 41 beds | Grade D | EBITDA uplift $976K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HIGHLANDS REGIONAL REHAB HOSPITAL

CCN 453086 | EL PASO, TX | 41 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

HIGHLANDS REGIONAL REHAB HOSPITAL is a 41-bed community hospital in EL PASO, TX with $13.2M in net patient revenue and a -9.7% operating margin. The hospital serves a payer mix of 38.1% Medicare, 0.0% Medicaid, and 61.9% commercial.

Thesis: Turnaround. Our ML models identify $976K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.7% to -2.3% (+738bps).

Net Revenue HCRIS$13.2M
Current EBITDA COMPUTED$-1.3M
Operating Margin COMPUTED-9.7%
Occupancy HCRIS55.1%
Revenue / Bed COMPUTED$323K
Net-to-Gross HCRIS49.8%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
278
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -9.7% places it below the state median. Among 278 size-comparable peers (20-82 beds), the median margin is -2.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-82), prioritizing same-state peers. 278 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HIGHLANDS REGIONAL REHAB HOSPI (Target)TX41$13.2M-9.7%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $976K (738bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$278K+210bp18mo
Cost to Collect4.5%2.5%$265K+200bp12mo
Denial Rate Reduction12.0%6.5%$263K+199bp12mo
A/R Days Reduction5200.0%3800.0%$161K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$278K
Cost to Collect
$265K
Denial Rate Reduction
$263K
A/R Days Reduction
$161K
Clean Claim Rate
$10K
Total EBITDA Uplift$976K
Current EBITDA$-1.3M
+ RCM Uplift+$976K
Pro Forma EBITDA$-305K
Current Margin-9.7%
Pro Forma Margin-2.3%
WC Released (1x)$508K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.0M$1.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.0M$803K0.00x-100.0%
Bull Case9.0x11.0x$-1.8M$3.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.8M$3.2M0.00x-100.0%
Bear Case11.0x10.0x$-2.2M$-2.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.2M$-3.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 278 hospitals with 20-82 beds
  • Same-state prioritization (n=279)
  • Comp margins: P25=-23.0% / P50=-2.4% / P75=10.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.